Log in
Sign up
Onyx Pharmaceuticals

Onyx Pharmaceuticals

A biopharmaceutical company developing and commercializing therapies for the treatment of cancer

OverviewStructured DataIssuesContributorsActivity
Contents

Onyx Pharmaceuticals is a biopharmaceutical company that engaged in developing and commercializing innovative therapies for improving the lives of people who suffer from cancer. The company focused on developing novel medicines targeting key molecular pathways.

Onyx has an important and growing multiple myeloma franchise, with Kyprolis® (carfilzomib) for Injection that has already been approved in the United States. Onyx possesses three partnered oncology assets that include: Stivarga® (regorafenib) tablets (a Bayer compound), Nexavar® (sorafenib) tablets (an Onyx and Bayer HealthCare Pharmaceuticals, Inc. compound), and palbociclib (a Pfizer, Inc. compound). Onyx also possesses several oncology compounds in stages of clinical development.

Amgen, a company that is committed to unlocking the potential of biology for patients who are suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics, had acquired Onyx Pharmaceuticals in 2013.

Timeline

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

onyx-pharm.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Fitness
Fitness
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
...
Location
San Francisco
San Francisco
South San Francisco, California
South San Francisco, California
-1
B2X
B2B
B2B
CEO
‌
N. Anthony Coles
-1
Legal Name
Onyx Pharmaceuticals, Inc.
Full Address
249 E. Grand Avenue South San Francisco, CA 94080-1
CIK Number
1,012,140-1
Place of Incorporation
Delaware
Delaware
-1
Investors
Ridgeback Capital
Ridgeback Capital
DUNS Number
789591724-1
IRS Number
943,154,463-1
Founded Date
January 1, 1992
Phone Number
+16502660000-1
Fax Number
650.266.0100-1
Stock Symbol
ONXX-1
Exchange
Nasdaq
Nasdaq
Board of Directors
‌
Bill Ringo
-1
‌
Thomas G. Wiggans
-1
Acquisition Transaction
‌
Acquisition of Onyx Pharmaceuticals by Amgen
CAGE Code
6SK83-1
Patents Assigned (Count)
1
Wellfound ID
onyx-pharmaceuticals

Other attributes

Acquirer
Amgen
Amgen
-1
Company Operating Status
Active
Country
United States
United States
-1
Headquarters
South San Francisco, California
South San Francisco, California
-1
SIC Code
2,836-1
Wikidata ID
Q7095196

Find more companies like Onyx Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
Knowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.